Macquarie Group
ATRC icon

Macquarie Group’s AtriCure ATRC Stock Holding History

Macquarie Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,289,369
Closed -$80.7M – 912
2025
Q3 		$80.7M Sell
2,289,369
-213,836
-9% -$7.37M 0.09% 284
2025
Q2 		$82M Buy
2,503,205
+66,368
+3% +$2.16M 0.1% 288
2025
Q1 		$78.6M Buy
2,436,837
+61,604
+3% +$2.29M 0.1% 300
2024
Q4 		$72.6M Sell
2,375,233
-9,583
-0.4% -$308K 0.09% 317
2024
Q3 		$66.9M Buy
2,384,816
+386,767
+19% +$9.53M 0.07% 361
2024
Q2 		$45.5M Buy
1,998,049
+584,824
+41% +$13.5M 0.05% 441
2024
Q1 		$43M Sell
1,413,225
-36,501
-3% -$1.22M 0.05% 473
2023
Q4 		$51.7M Sell
1,449,726
-8,775
-0.6% -$326K 0.06% 421
2023
Q3 		$63.9M Buy
1,458,501
+58,851
+4% +$2.87M 0.08% 333
2023
Q2 		$69.1M Sell
1,399,650
-9,652
-0.7% -$445K 0.08% 335
2023
Q1 		$58.4M Buy
1,409,302
+33,348
+2% +$1.38M 0.07% 365
2022
Q4 		$61.1M Buy
1,375,954
+13,588
+1% +$568K 0.07% 371
2022
Q3 		$53.3M Buy
1,362,366
+5,835
+0.4% +$267K 0.07% 402
2022
Q2 		$55.4M Buy
1,356,531
+199,788
+17% +$9.46M 0.06% 413
2022
Q1 		$76K Buy
1,156,743
+25,122
+2% +$1.63M 0.06% 386
2021
Q4 		$78.7M Buy
1,131,621
+37,911
+3% +$2.76M 0.07% 371
2021
Q3 		$76.1M Buy
1,093,710
+57,777
+6% +$4.45M 0.06% 390
2021
Q2 		$82.2M Buy
1,035,933
+274,381
+36% +$19.9M 0.07% 361
2021
Q1 		$49.9M Buy
761,552
+281,075
+58% +$17.3M 0.07% 334
2020
Q4 		$26.7M Buy
480,477
+439,279
+1,066% +$19M 0.04% 451
2020
Q3 		$1.64M Buy
41,198
+2,226
+6% +$94.4K ﹤0.01% 1096
2020
Q2 		$1.75M Sell
38,972
-1,816
-4% -$79.1K ﹤0.01% 1048
2020
Q1 		$1.37M Sell
40,788
-39,231
-49% -$1.41M ﹤0.01% 1013
2019
Q4 		$2.6M Sell
80,019
-4,919
-6% -$140K ﹤0.01% 962
2019
Q3 		$2.12M Buy
84,938
+15,070
+22% +$430K ﹤0.01% 1007
2019
Q2 		$2.08M Sell
69,868
-2,975
-4% -$86.9K ﹤0.01% 1003
2019
Q1 		$1.95M Buy
72,843
+7,057
+11% +$214K ﹤0.01% 997
2018
Q4 		$2.01M Buy
65,786
+681
+1% +$21.2K ﹤0.01% 964
2018
Q3 		$2.28M Sell
65,105
-24,559
-27% -$778K ﹤0.01% 983
2018
Q2 		$2.42M Sell
89,664
-7,750
-8% -$182K ﹤0.01% 947
2018
Q1 		$2M Sell
97,414
-2,642
-3% -$47.7K ﹤0.01% 986
2017
Q4 		$1.82M Buy
100,056
+17,811
+22% +$353K ﹤0.01% 1051
2017
Q3 		$1.84M Buy
82,245
+3,056
+4% +$69.1K ﹤0.01% 1009
2017
Q2 		$1.92M Sell
79,189
-8,121
-9% -$173K ﹤0.01% 983
2017
Q1 		$1.67M Sell
87,310
-186
-0.2% -$3.26K ﹤0.01% 1019
2016
Q4 		$1.71M Sell
87,496
-14,368
-14% -$260K ﹤0.01% 1007
2016
Q3 		$1.61M Sell
101,864
-82,736
-45% -$1.27M ﹤0.01% 1016
2016
Q2 		$2.61M Buy
+184,600
New +$2.81M ﹤0.01% 1076

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Macquarie Group's ATRC Position: Q4 2025 in Review

Macquarie Group sold out of AtriCure (ATRC) in Q4 2025, closing a stake of 2,289,369 shares — an estimated $80.7M sold.

Macquarie Group first reported a position in ATRC in Q2 2016 and held it in 38 quarters. The position peaked at $82.2M in Q2 2021. 234 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • Macquarie Group reported no remaining AtriCure position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 2,289,369 AtriCure shares in Q4 2025, an estimated $80.7M.
  • Macquarie Group first reported a position in AtriCure in Q2 2016 and held it in 38 quarters.
  • Macquarie Group's AtriCure position peaked at $82.2M in Q2 2021.
  • 234 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.